Header cover image
  • Investing Ideas
  • Spanish Pharmaceuticals & Biotech Top Stock Picks from Analysts

Spanish Pharmaceuticals & Biotech Top Stock Picks from Analysts

Results

1

0 new

Companies which are more than 50% undervalued based on analyst price target.

1 companies

Oryzon Genomics

Market Cap: €240.2m

A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system), oncology, and hematology disorders.

ORY

€2.92

7D

1.2%

1Y

13.8%